1. Home
  2. NUVL vs NFG Comparison

NUVL vs NFG Comparison

Compare NUVL & NFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$107.07

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Logo National Fuel Gas Company

NFG

National Fuel Gas Company

HOLD

Current Price

$81.36

Market Cap

7.3B

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUVL
NFG
Founded
2017
1902
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil/Gas Transmission
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
7.3B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
NUVL
NFG
Price
$107.07
$81.36
Analyst Decision
Strong Buy
Hold
Analyst Count
15
5
Target Price
$135.00
$91.20
AVG Volume (30 Days)
552.5K
765.2K
Earning Date
02-26-2026
01-28-2026
Dividend Yield
N/A
2.66%
EPS Growth
N/A
576.19
EPS
N/A
5.68
Revenue
N/A
$2,277,541,000.00
Revenue This Year
N/A
$15.96
Revenue Next Year
N/A
$24.46
P/E Ratio
N/A
$14.18
Revenue Growth
N/A
17.11
52 Week Low
$55.54
$63.66
52 Week High
$112.88
$94.13

Technical Indicators

Market Signals
Indicator
NUVL
NFG
Relative Strength Index (RSI) 54.67 52.56
Support Level $97.43 $77.80
Resistance Level $108.46 $82.53
Average True Range (ATR) 4.64 1.64
MACD 0.41 0.03
Stochastic Oscillator 81.51 70.61

Price Performance

Historical Comparison
NUVL
NFG

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

About NFG National Fuel Gas Company

National Fuel Gas Co is a diversified energy company engaged in the production, gathering, transportation, distribution, and marketing of natural gas. The operating segments of the company are the Exploration and Production segment, the Pipeline and Storage segment, the Gathering segment, and the Utility segment. The company generates a majority of its revenue from the Exploration and Production segment which is engaged in the exploration for, and the development and production of, natural gas in the Appalachian region of the United States. Geographically, the company operates in the United States.

Share on Social Networks: